Register entry

DIVI'S LABORATORIES LIMITED

Data as of · How to read this entry

Registered sites
2
Active NDC listings
45
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
DIVI'S LABORATORIES LIMITEDUnit-2, Chippada Village, Annavaram Post Bheemunipatnam Mandal, Visakhapatnam District, Andhra Pradesh 531162, India (IND)Analytical testing, Active ingredient (API) manufacture3004149463676446492
DIVI'S LABORATORIES LIMITEDUnit-1, Lingojigudem Village, Choutuppal Mandal,, Yadadri Bhuvanagiri District, Telangana 508252, India (IND)Analytical testing, Active ingredient (API) manufacture3003131136918598199
Catalogue

Drug listings by form and route

45

45 active NDC listings: 45 bulk ingredient. By marketing category: BULK INGREDIENT 45.

Dosage formNDCs
powder45
RouteNDCs
Labeller name on the listingNDCs
divi's laboratories limited45
Catalogue

Marketed products

45
BrandGeneric nameForm / routeNDC
-Alexidine Dihydrochloridepowder62331-053BULK INGREDIENT
-Atovaquonepowder62331-059BULK INGREDIENT
-Bupropion Hydrochloridepowder62331-025BULK INGREDIENT
-Capecitabinepowder62331-043BULK INGREDIENT
-Carbidopapowder62331-014BULK INGREDIENT
-Carvedilolpowder62331-036BULK INGREDIENT
-Desloratadinepowder62331-019BULK INGREDIENT
-Dextromethorphanpowder62331-004BULK INGREDIENT
-Dextromethorphan Hydrobromidepowder62331-003BULK INGREDIENT
-Diltiazem Hydrochloridepowder62331-005BULK INGREDIENT
-Foscarbidopapowder62331-068BULK INGREDIENT
-Foslevodopapowder62331-067BULK INGREDIENT
-Gabapentinpowder62331-031BULK INGREDIENT
-Iohexolpowder62331-066BULK INGREDIENT
-Iopamidolpowder62331-006BULK INGREDIENT
-Irbesartanpowder62331-051BULK INGREDIENT
-Lacosamidepowder62331-062BULK INGREDIENT
-Lamotriginepowder62331-047BULK INGREDIENT
-Levetiracetampowder62331-010BULK INGREDIENT
-Levodopapowder62331-013BULK INGREDIENT
-Mesalaminepowder62331-060BULK INGREDIENT
-Mesalaminepowder62331-064BULK INGREDIENT
-Molnupiravirpowder62331-063BULK INGREDIENT
-Nabumetonepowder62331-008BULK INGREDIENT
-Naproxenpowder62331-001BULK INGREDIENT
-Naproxenpowder62331-029BULK INGREDIENT
-Naproxen Sodiumpowder62331-002BULK INGREDIENT
-Naproxen Sodiumpowder62331-030BULK INGREDIENT
-Niacinpowder62331-016BULK INGREDIENT
-Olmesartan Medoxomilpowder62331-056BULK INGREDIENT
-Orlistatpowder62331-045BULK INGREDIENT
-Phenylephrine Hydrochloridepowder62331-028BULK INGREDIENT
-Pregabalinpowder62331-057BULK INGREDIENT
-Proguanil Hydrochloridepowder62331-023BULK INGREDIENT
-Quetiapine Fumaratepowder62331-039BULK INGREDIENT
-Raltegravir Potassiumpowder62331-055BULK INGREDIENT
-Sumatriptanpowder62331-048BULK INGREDIENT
-Sumatriptan Succinatepowder62331-049BULK INGREDIENT
-Ticagrelorpowder62331-065BULK INGREDIENT
-Triprolidine Hydrochloridepowder62331-046BULK INGREDIENT
-Valacyclovir Hydrochloridepowder62331-034BULK INGREDIENT
-Valsartanpowder62331-050BULK INGREDIENT
-Venlafaxine Hydrochloridepowder62331-044BULK INGREDIENT
-Vigabatrinpowder62331-042BULK INGREDIENT
-Xanomeline Tartratepowder62331-069BULK INGREDIENT
Neighbours

Registered in the same town

2
Compare

Comparable companies in India

Enquiry

Common questions

Is DIVI'S LABORATORIES LIMITED FDA approved?
DIVI'S LABORATORIES LIMITED holds 2 FDA-registered establishments in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are DIVI'S LABORATORIES LIMITED's drugs manufactured?
The FDA register lists Visakhapatnam District; Yadadri Bhuvanagiri District. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does DIVI'S LABORATORIES LIMITED make?
45 products are listed under DIVI'S LABORATORIES LIMITED in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.